Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1
Information source: National Institute on Drug Abuse (NIDA)
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Cocaine-Related Disorders
Intervention: Risperidone (Drug)
Phase: Phase 2
Sponsored by: National Institute on Drug Abuse (NIDA)
Official(s) and/or principal investigator(s):
Lawrence Price, M.D., Principal Investigator, Affiliation: Brown University
The purpose of this study is to evaluate use of risperidone with cocaine abusers. Study
measures incorporate an appropriate integration of behavioral and neurobiological indices.
Official title: Serotonin/Dopamine Antagonism of Cocaine Effect
Study design: Treatment, Randomized, Double-Blind
Analog mood scales
Minimum age: 18 Years.
Maximum age: 50 Years.
Please contact site for information.
Locations and Contacts
Brown University School of Medicine, Providence, Rhode Island 2906, United States
Starting date: August 1994
Last updated: June 23, 2005